Zimbabwe Approves Groundbreaking HIV Prevention Drug Lenacapavir
By Dickson Bandera Zimbabwe is poised to introduce Lenacapavir, a revolutionary HIV prevention drug, following its swift approval by the Medicines Control Authority of Zimbabwe (MCAZ). Lenacapavir—widely regarded as one of the most promising advancements in HIV prevention—is a long-acting injectable developed by Gilead Sciences. It is administered just twice a year, offering a convenient…